<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39451987</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-3425</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>27</Day></PubDate></JournalIssue><Title>Brain sciences</Title><ISOAbbreviation>Brain Sci</ISOAbbreviation></Journal><ArticleTitle>Reactive Astrocytosis-A Potential Contributor to Increased Suicide in Long COVID-19 Patients?</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">973</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/brainsci14100973</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Long COVID-19 is an emerging chronic illness of significant public health concern due to a myriad of neuropsychiatric sequelae, including increased suicidal ideation (SI) and behavior (SB).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This review provides a concise synthesis of clinical evidence that points toward the dysfunction of astrocytes, the most abundant glial cell type in the central nervous system, as a potential shared pathology between SI/SB and COVID-19.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Depression, a suicide risk factor, and SI/SB were both associated with reduced frequencies of various astrocyte subsets and complex proteomic/transcriptional changes of astrocyte-related markers in a brain-region-specific manner. Astrocyte-related circulating markers were increased in depressed subjects and, to a less consistent extent, in COVID-19 patients. Furthermore, reactive astrocytosis was observed in subjects with SI/SB and those with COVID-19.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Astrocyte dysfunctions occurred in depression, SI/SB, and COVID-19. Reactive-astrocyte-mediated loss of the blood-brain barrier (BBB) integrity and subsequent neuroinflammation-a factor previously linked to SI/SB development-might contribute to increased suicide in individuals with long COVID-19. As such, the formulation of new therapeutic strategies to restore astrocyte homeostasis, enhance BBB integrity, and mitigate neuroinflammation may reduce SI/SB-associated neuropsychiatric manifestations among long COVID-19 patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Costanza</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6387-6462</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, Faculty of Medicine, University of Geneva (UNIGE), 24 Rue du G&#xe9;n&#xe9;ral-Dufour, 1211 Geneva, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Faculty of Biomedical Sciences, University of Italian Switzerland (USI), Via Giuseppe Buffi 13, 6900 Lugano, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Adult Psychiatry Service, University Hospitals of Geneva (HUG), Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>"Nel Chiostro", Medical and Study Center, Via Camillo Leone 29, 13100 Vercelli, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amerio</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3439-340X</Identifier><AffiliationInfo><Affiliation>Section of Psychiatry, Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Via Balbi, 5, 16132 Genoa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCCS Polyclinic Hospital San Martino, Largo Rosanna Benzi 10, 16132 Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguglia</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2003-2101</Identifier><AffiliationInfo><Affiliation>Section of Psychiatry, Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Via Balbi, 5, 16132 Genoa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCCS Polyclinic Hospital San Martino, Largo Rosanna Benzi 10, 16132 Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossi</LastName><ForeName>Martina</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8866-1844</Identifier><AffiliationInfo><Affiliation>"Nel Chiostro", Medical and Study Center, Via Camillo Leone 29, 13100 Vercelli, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parise</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Geriatric-Rehabilitation Department, University Hospital of Parma, 43126 Parma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magnani</LastName><ForeName>Luca</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-3620-2021</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, San Maurizio Hospital of Bolzano, Via Lorenz B&#xf6;hler, 5, 39100 Bolzano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serafini</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-6631-856X</Identifier><AffiliationInfo><Affiliation>Section of Psychiatry, Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Via Balbi, 5, 16132 Genoa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCCS Polyclinic Hospital San Martino, Largo Rosanna Benzi 10, 16132 Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amore</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Section of Psychiatry, Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Via Balbi, 5, 16132 Genoa, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IRCCS Polyclinic Hospital San Martino, Largo Rosanna Benzi 10, 16132 Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martins</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-0239-8206</Identifier><AffiliationInfo><Affiliation>Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience (IoPPN)-King's College London (KCL), Strand Campus, London WC2R 2LS, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Maudesley BRC, 16 De Crespigny Park, SE5 8AF South London and Maudesley NHS Trust, Denmark Hill, London SE5 8AZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Khoa D</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>Program in Immunology, Stanford University, 450 Jane Stanford Way, Stanford, CA 94305, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Chinese University of Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Brain Sci</MedlineTA><NlmUniqueID>101598646</NlmUniqueID><ISSNLinking>2076-3425</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">astrocytes</Keyword><Keyword MajorTopicYN="N">blood&#x2013;brain barrier</Keyword><Keyword MajorTopicYN="N">depression</Keyword><Keyword MajorTopicYN="N">long COVID-19</Keyword><Keyword MajorTopicYN="N">neuroinflammation</Keyword><Keyword MajorTopicYN="N">reactive astrocytosis</Keyword><Keyword MajorTopicYN="N">suicidal behavior</Keyword><Keyword MajorTopicYN="N">suicidal ideation</Keyword></KeywordList><CoiStatement>K.D.N. is the scientific founder of Tranquis Therapeutics, a biotechnology company that develops novel treatments for neuroinflammatory and neurodegenerative diseases. K.D.N. is also a scientific advisor for Tochikunda, a biotechnology company that develops SARS-CoV-2 diagnostic devices. However, this had no impact on the interpretation of data, the writing of this review, or its publication. All other authors declare no conflicts of interest and that they have no commercial associations (e.g., consultancies, stock ownership, equity interest, patent/licensing arrangement, etc.) that might pose a conflict of interest in connection with the submitted article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>9</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39451987</ArticleId><ArticleId IdType="pmc">PMC11505806</ArticleId><ArticleId IdType="doi">10.3390/brainsci14100973</ArticleId><ArticleId IdType="pii">brainsci14100973</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO  COVID-19 Cases. COVID-19 Dashboard 2024.  [(accessed on 6 February 2024)].  Available online:  https://data.who.int/dashboards/covid19/cases.</Citation></Reference><Reference><Citation>Russell C.D., Lone N.I., Baillie J.K. Comorbidities, multimorbidity and COVID-19. Nat. Med. 2023;29:334&#x2013;343. doi: 10.1038/s41591-022-02156-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02156-9</ArticleId><ArticleId IdType="pubmed">36797482</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L., Kannapadi N.V., Briggs J., Seal S.M., Battaglini D., Fanning J., Suen J., Robba C., Fraser J., Cho S.M. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J. Neurol. Sci. 2022;434:120162. doi: 10.1016/j.jns.2022.120162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalleballe K., Reddy Onteddu S., Sharma R., Dandu V., Brown A., Jasti M., Yadala S., Veerapaneni K., Siddamreddy S., Avula A. Spectrum of neuropsychiatric manifestations in COVID-19. Brain Behav. Immun. 2020;88:71&#x2013;74. doi: 10.1016/j.bbi.2020.06.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.06.020</ArticleId><ArticleId IdType="pmc">PMC7297688</ArticleId><ArticleId IdType="pubmed">32561222</ArticleId></ArticleIdList></Reference><Reference><Citation>Barlattani T., D&#x2019;Amelio C., Capelli F., Mantenuto S., Rossi R., Socci V., Stratta P., Di Stefano R., Rossi A., Pacitti F. Suicide and COVID-19: A rapid scoping review. Ann. Gen. Psychiatry. 2023;22:10. doi: 10.1186/s12991-023-00441-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12991-023-00441-6</ArticleId><ArticleId IdType="pmc">PMC10020759</ArticleId><ArticleId IdType="pubmed">36932453</ArticleId></ArticleIdList></Reference><Reference><Citation>Mati&#x107; T., Pregelj P., Sadikov A., Rus Prelog P. Depression, Anxiety, Stress, and Suicidality Levels in Young Adults Increased Two Years into the COVID-19 Pandemic. Int. J. Environ. Res. Public Health. 2022;20:339. doi: 10.3390/ijerph20010339.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20010339</ArticleId><ArticleId IdType="pmc">PMC9819448</ArticleId><ArticleId IdType="pubmed">36612666</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M., Hu C., Zhao Q., Feng R., Wang Q., Cai H., Guo Z., Xu K., Luo W., Guo C., et al. Acute psychological impact on COVID-19 patients in Hubei: A multicenter observational study. Transl. Psychiatry. 2021;11:133. doi: 10.1038/s41398-021-01259-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-021-01259-0</ArticleId><ArticleId IdType="pmc">PMC7890099</ArticleId><ArticleId IdType="pubmed">33602920</ArticleId></ArticleIdList></Reference><Reference><Citation>Erlangsen A., Qin P., Madsen T., Hawton K., Osler M., Hjorth&#xf8;j C., Benros M.E., Ethelberg S., M&#xf8;lbak K., Laursen T.M., et al. Association between SARS-CoV-2 infection and self-harm: Danish nationwide register-based cohort study. Br. J. Psychiatry J. Ment. Sci. 2023;222:167&#x2013;174. doi: 10.1192/bjp.2022.194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.2022.194</ArticleId><ArticleId IdType="pmc">PMC10895503</ArticleId><ArticleId IdType="pubmed">36636817</ArticleId></ArticleIdList></Reference><Reference><Citation>Sher L. Long COVID and the risk of suicide. Gen. Hosp. Psychiatry. 2023;80:66&#x2013;67. doi: 10.1016/j.genhosppsych.2022.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2022.12.001</ArticleId><ArticleId IdType="pmc">PMC9721155</ArticleId><ArticleId IdType="pubmed">36494289</ArticleId></ArticleIdList></Reference><Reference><Citation>Costanza A., Amerio A., Aguglia A., Serafini G., Amore M., Hasler R., Ambrosetti J., Bondolfi G., Sampogna G., Berardelli I., et al. Hyper/neuroinflammation in COVID-19 and suicide etiopathogenesis: Hypothesis for a nefarious collision? Neurosci. Biobehav. Rev. 2022;136:104606. doi: 10.1016/j.neubiorev.2022.104606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2022.104606</ArticleId><ArticleId IdType="pmc">PMC8916836</ArticleId><ArticleId IdType="pubmed">35289272</ArticleId></ArticleIdList></Reference><Reference><Citation>Steardo L., Steardo L., Jr., Scuderi C. Astrocytes and the Psychiatric Sequelae of COVID-19: What We Learned from the Pandemic. Neurochem. Res. 2023;48:1015&#x2013;1025. doi: 10.1007/s11064-022-03709-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-022-03709-7</ArticleId><ArticleId IdType="pmc">PMC9362636</ArticleId><ArticleId IdType="pubmed">35922744</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma D.K., Bonaguidi M.A., Ming G.-L., Song H. Adult neural stem cells in the mammalian central nervous system. Cell Res. 2009;19:672&#x2013;682. doi: 10.1038/cr.2009.56.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2009.56</ArticleId><ArticleId IdType="pmc">PMC2738865</ArticleId><ArticleId IdType="pubmed">19436263</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandrasekaran A., Avci H.X., Leist M., Kobol&#xe1;k J., Dinny&#xe9;s A. Astrocyte Differentiation of Human Pluripotent Stem Cells: New Tools for Neurological Disorder Research. Front. Cell. Neurosci. 2016;10:215. doi: 10.3389/fncel.2016.00215.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2016.00215</ArticleId><ArticleId IdType="pmc">PMC5035736</ArticleId><ArticleId IdType="pubmed">27725795</ArticleId></ArticleIdList></Reference><Reference><Citation>Sofroniew M.V., Vinters H.V. Astrocytes: Biology and pathology. Acta Neuropathol. 2010;119:7&#x2013;35. doi: 10.1007/s00401-009-0619-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-009-0619-8</ArticleId><ArticleId IdType="pmc">PMC2799634</ArticleId><ArticleId IdType="pubmed">20012068</ArticleId></ArticleIdList></Reference><Reference><Citation>Verkhratsky A., Nedergaard M. Physiology of Astroglia. Physiol. Rev. 2018;98:239&#x2013;389. doi: 10.1152/physrev.00042.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00042.2016</ArticleId><ArticleId IdType="pmc">PMC6050349</ArticleId><ArticleId IdType="pubmed">29351512</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbott N.J., R&#xf6;nnb&#xe4;ck L., Hansson E. Astrocyte&#x2013;endothelial interactions at the blood&#x2013;brain barrier. Nat. Rev. Neurosci. 2006;7:41&#x2013;53. doi: 10.1038/nrn1824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1824</ArticleId><ArticleId IdType="pubmed">16371949</ArticleId></ArticleIdList></Reference><Reference><Citation>Magistretti P.J., Pellerin L., Rothman D.L., Shulman R.G. Energy on Demand. Science. 1999;283:496&#x2013;497. doi: 10.1126/science.283.5401.496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.283.5401.496</ArticleId><ArticleId IdType="pubmed">9988650</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnewald U., Westergaard N., Schousboe A. Glutamate transport and metabolism in astrocytes. Glia. 1997;21:56&#x2013;63. doi: 10.1002/(SICI)1098-1136(199709)21:1&lt;56::AID-GLIA6&gt;3.0.CO;2-#.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1098-1136(199709)21:1&lt;56::AID-GLIA6&gt;3.0.CO;2-#</ArticleId><ArticleId IdType="pubmed">9298847</ArticleId></ArticleIdList></Reference><Reference><Citation>Iliff J.J., Wang M., Liao Y., Plogg B.A., Peng W., Gundersen G.A., Benveniste H., Vates G.E., Deane R., Goldman S.A., et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid &#x3b2;. Sci. Transl. Med. 2012;4:147ra111. doi: 10.1126/scitranslmed.3003748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3003748</ArticleId><ArticleId IdType="pmc">PMC3551275</ArticleId><ArticleId IdType="pubmed">22896675</ArticleId></ArticleIdList></Reference><Reference><Citation>Verkhratsky A., Matteoli M., Parpura V., Mothet J.-P., Zorec R. Astrocytes as secretory cells of the central nervous system: Idiosyncrasies of vesicular secretion. EMBO J. 2016;35:239&#x2013;257. doi: 10.15252/embj.201592705.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201592705</ArticleId><ArticleId IdType="pmc">PMC4741299</ArticleId><ArticleId IdType="pubmed">26758544</ArticleId></ArticleIdList></Reference><Reference><Citation>Takata F., Nakagawa S., Matsumoto J., Dohgu S. Blood-Brain Barrier Dysfunction Amplifies the Development of Neuroinflammation: Understanding of Cellular Events in Brain Microvascular Endothelial Cells for Prevention and Treatment of BBB Dysfunction. Front. Cell. Neurosci. 2021;15:661838. doi: 10.3389/fncel.2021.661838.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.661838</ArticleId><ArticleId IdType="pmc">PMC8475767</ArticleId><ArticleId IdType="pubmed">34588955</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue Q., Hoi M.P.M. Emerging roles of astrocytes in blood-brain barrier disruption upon amyloid-beta insults in Alzheimer&#x2019;s disease. Neural Regen. Res. 2023;18:1890&#x2013;1902. doi: 10.4103/1673-5374.367832.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.367832</ArticleId><ArticleId IdType="pmc">PMC10233760</ArticleId><ArticleId IdType="pubmed">36926705</ArticleId></ArticleIdList></Reference><Reference><Citation>Pekny M., Pekna M. Reactive gliosis in the pathogenesis of CNS diseases. Biochim. Biophys. Acta (BBA)&#x2014;Mol. Basis Dis. 2016;1862:483&#x2013;491. doi: 10.1016/j.bbadis.2015.11.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2015.11.014</ArticleId><ArticleId IdType="pubmed">26655603</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Leary L.A., Mechawar N. Implication of cerebral astrocytes in major depression: A review of fine neuroanatomical evidence in humans. Glia. 2021;69:2077&#x2013;2099. doi: 10.1002/glia.23994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23994</ArticleId><ArticleId IdType="pubmed">33734498</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto M., Sakai M., Yu Z., Nakanishi M., Yoshii H. Glial Markers of Suicidal Behavior in the Human Brain-A Systematic Review of Postmortem Studies. Int. J. Mol. Sci. 2024;25:5750. doi: 10.3390/ijms25115750.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms25115750</ArticleId><ArticleId IdType="pmc">PMC11171620</ArticleId><ArticleId IdType="pubmed">38891940</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernstein H.-G., Meyer-Lotz G., Dobrowolny H., Bannier J., Steiner J., Walter M., Bogerts B. Reduced density of glutamine synthetase immunoreactive astrocytes in different cortical areas in major depression but not in bipolar I disorder. Front. Cell. Neurosci. 2015;9:273. doi: 10.3389/fncel.2015.00273.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00273</ArticleId><ArticleId IdType="pmc">PMC4530620</ArticleId><ArticleId IdType="pubmed">26321908</ArticleId></ArticleIdList></Reference><Reference><Citation>Gos T., Schroeter M.L., Lessel W., Bernstein H.-G., Dobrowolny H., Schiltz K., Bogerts B., Steiner J. S100B-immunopositive astrocytes and oligodendrocytes in the hippocampus are differentially afflicted in unipolar and bipolar depression: A postmortem study. J. Psychiatr. Res. 2013;47:1694&#x2013;1699. doi: 10.1016/j.jpsychires.2013.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2013.07.005</ArticleId><ArticleId IdType="pubmed">23896207</ArticleId></ArticleIdList></Reference><Reference><Citation>Cobb J.A., O&#x2019;Neill K., Milner J., Mahajan G.J., Lawrence T.J., May W.L., Miguel-Hidalgo J., Rajkowska G., Stockmeier C.A. Density of GFAP-immunoreactive astrocytes is decreased in left hippocampi in major depressive disorder. Neuroscience. 2016;316:209&#x2013;220. doi: 10.1016/j.neuroscience.2015.12.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.12.044</ArticleId><ArticleId IdType="pmc">PMC4836620</ArticleId><ArticleId IdType="pubmed">26742791</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis S., Thomas A., Perry R., Oakley A., Kalaria R.N., O&#x2019;Brien J.T. Glial fibrillary acidic protein in late life major depressive disorder: An immunocytochemical study. J. Neurol. Neurosurg. Psychiatry. 2002;73:556&#x2013;560. doi: 10.1136/jnnp.73.5.556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.73.5.556</ArticleId><ArticleId IdType="pmc">PMC1738142</ArticleId><ArticleId IdType="pubmed">12397151</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh D.H., Son H., Hwang S., Kim S.H. Neuropathological abnormalities of astrocytes, GABAergic neurons, and pyramidal neurons in the dorsolateral prefrontal cortices of patients with major depressive disorder. Eur. Neuropsychopharmacol. 2012;22:330&#x2013;338. doi: 10.1016/j.euroneuro.2011.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2011.09.001</ArticleId><ArticleId IdType="pubmed">21962915</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodnight R., Gon&#xe7;alves C.A., Wofchuk S.T., Leal R. Control of the phosphorylation of the astrocyte marker glial fibrillary acidic protein (GFAP) in the immature rat hippocampus by glutamate and calcium ions: Possible key factor in astrocytic plasticity. Braz. J. Med. Biol. Res. 1997;30:325&#x2013;338. doi: 10.1590/S0100-879X1997000300005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0100-879X1997000300005</ArticleId><ArticleId IdType="pubmed">9246230</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster M.J., Knable M.B., Johnston-Wilson N., Nagata K., Inagaki M., Yolken R.H. Immunohistochemical Localization of Phosphorylated Glial Fibrillary Acidic Protein in the Prefrontal Cortex and Hippocampus from Patients with Schizophrenia, Bipolar Disorder, and Depression. Brain Behav. Immun. 2001;15:388&#x2013;400. doi: 10.1006/brbi.2001.0646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/brbi.2001.0646</ArticleId><ArticleId IdType="pubmed">11782105</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandley M.J., Szebeni K., Szebeni A., Crawford J., Stockmeier C.A., Turecki G., Miguel-Hidalgo J.J., Ordway G.A. Gene expression deficits in pontine locus coeruleus astrocytes in men with major depressive disorder. J. Psychiatry Neurosci. JPN. 2013;38:276&#x2013;284. doi: 10.1503/jpn.120110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/jpn.120110</ArticleId><ArticleId IdType="pmc">PMC3692725</ArticleId><ArticleId IdType="pubmed">23415275</ArticleId></ArticleIdList></Reference><Reference><Citation>Medina A., Watson S.J., Bunney W., Jr., Myers R.M., Schatzberg A., Barchas J., Akil H., Thompson R.C. Evidence for alterations of the glial syncytial function in major depressive disorder. J. Psychiatr. Res. 2016;72:15&#x2013;21. doi: 10.1016/j.jpsychires.2015.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2015.10.010</ArticleId><ArticleId IdType="pmc">PMC5813495</ArticleId><ArticleId IdType="pubmed">26519765</ArticleId></ArticleIdList></Reference><Reference><Citation>Miguel-Hidalgo J.J., Wilson B.A., Hussain S., Meshram A., Rajkowska G., Stockmeier C.A. Reduced connexin 43 immunolabeling in the orbitofrontal cortex in alcohol dependence and depression. J. Psychiatr. Res. 2014;55:101&#x2013;109. doi: 10.1016/j.jpsychires.2014.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2014.04.007</ArticleId><ArticleId IdType="pmc">PMC4078739</ArticleId><ArticleId IdType="pubmed">24774648</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang K., Xie G.-R., Hu Y.-Q., Mao F.-Q., Su L.-Y. Association Study of Astrocyte-Derived Protein S100B Gene Polymorphisms with Major Depressive Disorder in Chinese People. Can. J. Psychiatry. 2009;54:312&#x2013;319. doi: 10.1177/070674370905400505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/070674370905400505</ArticleId><ArticleId IdType="pubmed">19497163</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.-K., Kim S.G., Kim H.J., Song Y.R. Serum S100B protein is associated with depressive symptoms in patients with end-stage renal disease. Clin. Biochem. 2012;45:1573&#x2013;1577. doi: 10.1016/j.clinbiochem.2012.08.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinbiochem.2012.08.014</ArticleId><ArticleId IdType="pubmed">22935566</ArticleId></ArticleIdList></Reference><Reference><Citation>Tulner D.M., Smith O.R.F., de Jonge P., van Melle J.P., Slomp J., Storm H., Quere M., den Boer J.A., Honig A., Korf J. Circulating Cerebral S100B Protein Is Associated with Depressive Symptoms following Myocardial Infarction. Neuropsychobiology. 2009;59:87&#x2013;95. doi: 10.1159/000209860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000209860</ArticleId><ArticleId IdType="pubmed">19325251</ArticleId></ArticleIdList></Reference><Reference><Citation>Benitez A., Gunstad J., Hughes J., Glickman E., Alexander T., Spitznagel M.B., Juvancic-Heltzel J., Murray L. Troponin and S100&#x3b2; are associated with depression in healthy older adults. Aging Ment. Health. 2009;13:894&#x2013;898. doi: 10.1080/13607860903046438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607860903046438</ArticleId><ArticleId IdType="pubmed">19888709</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulen B., Serinken M., Eken C., Karc&#x131;oglu &#xd6;., Kucukdagli O.T., Kilic E., Akpinar G., Nogay S., Kuh M. Serum S100B as a Surrogate Biomarker in the Diagnoses of Burnout and Depression in Emergency Medicine Residents. Acad. Emerg. Med. 2016;23:786&#x2013;789. doi: 10.1111/acem.12973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acem.12973</ArticleId><ArticleId IdType="pubmed">27018399</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Wilder-Smith C.H., Kan M.E., Lu J., Cao Y., Wong R.K. Combat-training stress in soldiers increases S100B, a marker of increased blood-brain-barrier permeability, and induces immune activation. Neuro Endocrinol. Lett. 2014;35:58&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">24625912</ArticleId></ArticleIdList></Reference><Reference><Citation>Tural U., Irvin M.K., Iosifescu D.V. Correlation between S100B and severity of depression in MDD: A meta-analysis. World J. Biol. Psychiatry. 2021;23:456&#x2013;463. doi: 10.1080/15622975.2021.2013042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15622975.2021.2013042</ArticleId><ArticleId IdType="pubmed">34854356</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeter M.L., Abdul-Khaliq H., Krebs M., Diefenbacher A., Blasig I.E. Serum markers support disease-specific glial pathology in major depression. J. Affect. Disord. 2008;111:271&#x2013;280. doi: 10.1016/j.jad.2008.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2008.03.005</ArticleId><ArticleId IdType="pubmed">18430474</ArticleId></ArticleIdList></Reference><Reference><Citation>Arolt V., Peters M., Erfurth A., Wiesmann M., Missler U., Rudolf S., Kirchner H., Rothermundt M. S100B and response to treatment in major depression: A pilot study. Eur. Neuropsychopharmacol. 2003;13:235&#x2013;239. doi: 10.1016/S0924-977X(03)00016-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0924-977X(03)00016-6</ArticleId><ArticleId IdType="pubmed">12888182</ArticleId></ArticleIdList></Reference><Reference><Citation>Navin&#xe9;s R., Oriolo G., Horrillo I., Cavero M., Aouizerate B., Schaefer M., Capuron L., Meana J.J., Martin-Santos R. High S100B Levels Predict Antidepressant Response in Patients with Major Depression Even When Considering Inflammatory and Metabolic Markers. Int. J. Neuropsychopharmacol. 2022;25:468&#x2013;478. doi: 10.1093/ijnp/pyac016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ijnp/pyac016</ArticleId><ArticleId IdType="pmc">PMC9211008</ArticleId><ArticleId IdType="pubmed">35176771</ArticleId></ArticleIdList></Reference><Reference><Citation>Michel M., Fiebich B.L., Kuzior H., Meixensberger S., Berger B., Maier S., Nickel K., Runge K., Denzel D., Pankratz B., et al. Increased GFAP concentrations in the cerebrospinal fluid of patients with unipolar depression. Transl. Psychiatry. 2021;11:308. doi: 10.1038/s41398-021-01423-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-021-01423-6</ArticleId><ArticleId IdType="pmc">PMC8139962</ArticleId><ArticleId IdType="pubmed">34021122</ArticleId></ArticleIdList></Reference><Reference><Citation>Endres D., Lerchenm&#xfc;ller V., Runge K., von Zedtwitz K., Nickel K., Urbach H., Domschke K., Pr&#xfc;ss H., Tebartz van Elst L. Anti-astrocytic autoantibody patterns in the cerebrospinal fluid of patients with depression and psychosis. Psychiatry Res. 2022;317:114905. doi: 10.1016/j.psychres.2022.114905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2022.114905</ArticleId><ArticleId IdType="pubmed">36265195</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinacker P., Al Shweiki M.H.D.R., Oeckl P., Graf H., Ludolph A.C., Sch&#xf6;nfeldt-Lecuona C., Otto M. Glial fibrillary acidic protein as blood biomarker for differential diagnosis and severity of major depressive disorder. J. Psychiatr. Res. 2021;144:54&#x2013;58. doi: 10.1016/j.jpsychires.2021.09.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2021.09.012</ArticleId><ArticleId IdType="pubmed">34600287</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallensten J., Nager A., &#xc5;sberg M., Borg K., Beser A., Wilczek A., Mobarrez F. Leakage of astrocyte-derived extracellular vesicles in stress-induced exhaustion disorder: A cross-sectional study. Sci. Rep. 2021;11:2009. doi: 10.1038/s41598-021-81453-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-81453-8</ArticleId><ArticleId IdType="pmc">PMC7820323</ArticleId><ArticleId IdType="pubmed">33479350</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi X.-R., Kamphuis W., Shan L. Astrocyte Changes in the Prefrontal Cortex From Aged Non-suicidal Depressed Patients. Front. Cell. Neurosci. 2019;13:503. doi: 10.3389/fncel.2019.00503.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00503</ArticleId><ArticleId IdType="pmc">PMC6874137</ArticleId><ArticleId IdType="pubmed">31798416</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka M., Yamaguchi K., Tatsukawa T., Nishioka C., Nishiyama H., Theis M., Willecke K., Itohara S. Lack of Connexin43-mediated bergmann glial gap junctional coupling does not affect cerebellar long-term depression, motor coordination, or eyeblink conditioning. Front. Behav. Neurosci. 2008;2:1. doi: 10.3389/neuro.08.001.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/neuro.08.001.2008</ArticleId><ArticleId IdType="pmc">PMC2525865</ArticleId><ArticleId IdType="pubmed">18958191</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres-Platas S.G., Hercher C., Davoli M.A., Maussion G., Labont&#xe9; B., Turecki G., Mechawar N. Astrocytic hypertrophy in anterior cingulate white matter of depressed suicides. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 2011;36:2650&#x2013;2658. doi: 10.1038/npp.2011.154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/npp.2011.154</ArticleId><ArticleId IdType="pmc">PMC3230489</ArticleId><ArticleId IdType="pubmed">21814185</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlicht K., B&#xfc;ttner A., Siedler F., Scheffer B., Zill P., Eisenmenger W., Ackenheil M., Bondy B. Comparative proteomic analysis with postmortem prefrontal cortex tissues of suicide victims versus controls. J. Psychiatr. Res. 2007;41:493&#x2013;501. doi: 10.1016/j.jpsychires.2006.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2006.04.006</ArticleId><ArticleId IdType="pubmed">16750834</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres-Platas S.G., Nagy C., Wakid M., Turecki G., Mechawar N. Glial fibrillary acidic protein is differentially expressed across cortical and subcortical regions in healthy brains and downregulated in the thalamus and caudate nucleus of depressed suicides. Mol. Psychiatry. 2015;21:509&#x2013;515. doi: 10.1038/mp.2015.65.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2015.65</ArticleId><ArticleId IdType="pubmed">26033239</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy C., Suderman M., Yang J., Szyf M., Mechawar N., Ernst C., Turecki G. Astrocytic abnormalities and global DNA methylation patterns in depression and suicide. Mol. Psychiatry. 2015;20:320&#x2013;328. doi: 10.1038/mp.2014.21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2014.21</ArticleId><ArticleId IdType="pmc">PMC5293540</ArticleId><ArticleId IdType="pubmed">24662927</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Leary L.A., Belliveau C., Davoli M.A., Ma J.C., Tanti A., Turecki G., Mechawar N. Widespread Decrease of Cerebral Vimentin-Immunoreactive Astrocytes in Depressed Suicides. Front. Psychiatry. 2021;12:640963. doi: 10.3389/fpsyt.2021.640963.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.640963</ArticleId><ArticleId IdType="pmc">PMC7890082</ArticleId><ArticleId IdType="pubmed">33613346</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Verwer R.W.H., Zhao J., Huitinga I., Lucassen P.J., Swaab D.F. Changes in glial gene expression in the prefrontal cortex in relation to major depressive disorder, suicide and psychotic features. J. Affect. Disord. 2021;295:893&#x2013;903. doi: 10.1016/j.jad.2021.08.098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2021.08.098</ArticleId><ArticleId IdType="pubmed">34706460</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Verwer R.W.H., Lucassen P.J., Huitinga I., Swaab D.F. Prefrontal cortex alterations in glia gene expression in schizophrenia with and without suicide. J. Psychiatr. Res. 2020;121:31&#x2013;38. doi: 10.1016/j.jpsychires.2019.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2019.11.002</ArticleId><ArticleId IdType="pubmed">31739114</ArticleId></ArticleIdList></Reference><Reference><Citation>Maussion G., Yang J., Suderman M., Diallo A., Nagy C., Arnovitz M., Mechawar N., Turecki G. Functional DNA methylation in a transcript specific 3&#x2019;UTR region of TrkB associates with suicide. Epigenetics. 2014;9:1061&#x2013;1070. doi: 10.4161/epi.29068.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/epi.29068</ArticleId><ArticleId IdType="pmc">PMC4164491</ArticleId><ArticleId IdType="pubmed">24802768</ArticleId></ArticleIdList></Reference><Reference><Citation>Maussion G., Yang J., Yerko V., Barker P., Mechawar N., Ernst C., Turecki G. Regulation of a truncated form of tropomyosin-related kinase B (TrkB) by Hsa-miR-185* in frontal cortex of suicide completers. PLoS ONE. 2012;7:e39301. doi: 10.1371/journal.pone.0039301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0039301</ArticleId><ArticleId IdType="pmc">PMC3382618</ArticleId><ArticleId IdType="pubmed">22802923</ArticleId></ArticleIdList></Reference><Reference><Citation>Pantazatos S.P., Huang Y.Y., Rosoklija G.B., Dwork A.J., Arango V., Mann J.J. Whole-transcriptome brain expression and exon-usage profiling in major depression and suicide: Evidence for altered glial, endothelial and ATPase activity. Mol. Psychiatry. 2017;22:760&#x2013;773. doi: 10.1038/mp.2016.130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2016.130</ArticleId><ArticleId IdType="pmc">PMC5313378</ArticleId><ArticleId IdType="pubmed">27528462</ArticleId></ArticleIdList></Reference><Reference><Citation>Ernst C., Nagy C., Kim S., Yang J.P., Deng X., Hellstrom I.C., Choi K.H., Gershenfeld H., Meaney M.J., Turecki G. Dysfunction of Astrocyte Connexins 30 and 43 in Dorsal Lateral Prefrontal Cortex of Suicide Completers. Biol. Psychiatry. 2011;70:312&#x2013;319. doi: 10.1016/j.biopsych.2011.03.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2011.03.038</ArticleId><ArticleId IdType="pubmed">21571253</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy C., Torres-Platas S.G., Mechawar N., Turecki G. Repression of Astrocytic Connexins in Cortical and Subcortical Brain Regions and Prefrontal Enrichment of H3K9me3 in Depression and Suicide. Int. J. Neuropsychopharmacol. 2017;20:50&#x2013;57. doi: 10.1093/ijnp/pyw071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ijnp/pyw071</ArticleId><ArticleId IdType="pmc">PMC5737582</ArticleId><ArticleId IdType="pubmed">27516431</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanti A., Lutz P.-E., Kim J., O&#x2019;Leary L., Th&#xe9;roux J.-F., Turecki G., Mechawar N. Evidence of decreased gap junction coupling between astrocytes and oligodendrocytes in the anterior cingulate cortex of depressed suicides. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 2019;44:2099&#x2013;2111. doi: 10.1038/s41386-019-0471-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41386-019-0471-z</ArticleId><ArticleId IdType="pmc">PMC6897926</ArticleId><ArticleId IdType="pubmed">31374562</ArticleId></ArticleIdList></Reference><Reference><Citation>Ventorp F., Barzilay R., Erhardt S., Samuelsson M., Tr&#xe4;skman-Bendz L., Janelidze S., Weizman A., Offen D., Brundin L. The CD44 ligand hyaluronic acid is elevated in the cerebrospinal fluid of suicide attempters and is associated with increased blood&#x2013;brain barrier permeability. J. Affect. Disord. 2016;193:349&#x2013;354. doi: 10.1016/j.jad.2015.12.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2015.12.069</ArticleId><ArticleId IdType="pubmed">26796235</ArticleId></ArticleIdList></Reference><Reference><Citation>Dogan K.H., Unaldi M., Demirci S. Evaluation of Postmortem Cerebrospinal Fluid S100B Protein and Serotonin Levels: Comparison of Suicidal Versus Nonsuicidal Deaths in Konya, Turkey. J. Forensic Sci. 2016;61:1285&#x2013;1291. doi: 10.1111/1556-4029.13124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1556-4029.13124</ArticleId><ArticleId IdType="pubmed">27282656</ArticleId></ArticleIdList></Reference><Reference><Citation>Falcone T., Fazio V., Lee C., Simon B., Franco K., Marchi N., Janigro D. Serum S100B: A potential biomarker for suicidality in adolescents? PLoS ONE. 2010;5:e11089. doi: 10.1371/journal.pone.0011089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0011089</ArticleId><ArticleId IdType="pmc">PMC2885416</ArticleId><ArticleId IdType="pubmed">20559426</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu C.L., Ren J., Cao X. An astroglial basis of major depressive disorder: Molecular, Cellular, and Circuit Features. Biol. Psychiatry. 2024 doi: 10.1016/j.biopsych.2024.07.017. online ahead of print .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2024.07.017</ArticleId><ArticleId IdType="pubmed">39084500</ArticleId></ArticleIdList></Reference><Reference><Citation>Boroujeni M.E., Simani L., Bluyssen H.A.R., Samadikhah H.R., Zamanlui Benisi S., Hassani S., Akbari Dilmaghani N., Fathi M., Vakili K., Mahmoudiasl G.R., et al. Inflammatory Response Leads to Neuronal Death in Human Post-Mortem Cerebral Cortex in Patients with COVID-19. ACS Chem. Neurosci. 2021;12:2143&#x2013;2150. doi: 10.1021/acschemneuro.1c00111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.1c00111</ArticleId><ArticleId IdType="pubmed">34100287</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichard R.R., Kashani K.B., Boire N.A., Constantopoulos E., Guo Y., Lucchinetti C.F. Neuropathology of COVID-19: A spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol. 2020;140:1&#x2013;6. doi: 10.1007/s00401-020-02166-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02166-2</ArticleId><ArticleId IdType="pmc">PMC7245994</ArticleId><ArticleId IdType="pubmed">32449057</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.-H., Perl D.P., Nair G., Li W., Maric D., Murray H., Dodd S.J., Koretsky A.P., Watts J.A., Cheung V., et al. Microvascular Injury in the Brains of Patients with Covid-19. N. Engl. J. Med. 2021;384:481&#x2013;483. doi: 10.1056/NEJMc2033369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2033369</ArticleId><ArticleId IdType="pmc">PMC7787217</ArticleId><ArticleId IdType="pubmed">33378608</ArticleId></ArticleIdList></Reference><Reference><Citation>Aceti A., Margarucci L.M., Scaramucci E., Orsini M., Salerno G., Di Sante G., Gianfranceschi G., Di Liddo R., Valeriani F., Ria F., et al. Serum S100B protein as a marker of severity in Covid-19 patients. Sci. Rep. 2020;10:18665. doi: 10.1038/s41598-020-75618-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-75618-0</ArticleId><ArticleId IdType="pmc">PMC7596559</ArticleId><ArticleId IdType="pubmed">33122776</ArticleId></ArticleIdList></Reference><Reference><Citation>Mete E., Sabirli R., Goren T., Turkcuer I., Kurt &#xd6;., Koseler A. Association between S100b Levels and COVID-19 Pneumonia: A Case Control Study. Vivo. 2021;35:2923&#x2013;2928. doi: 10.21873/invivo.12583.</Citation><ArticleIdList><ArticleId IdType="doi">10.21873/invivo.12583</ArticleId><ArticleId IdType="pmc">PMC8408717</ArticleId><ArticleId IdType="pubmed">34410988</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva R.C., da Rosa M.M., Le&#xe3;o H.I., Silva E.D.L., Ferreira N.T., Albuquerque A.P.B., Duarte G.S., Siqueira A.M., Pereira M.C., R&#xea;go M.J.B.M., et al. Brain damage serum biomarkers induced by COVID-19 in patients from northeast Brazil. J. Neurovirology. 2023;29:180&#x2013;186. doi: 10.1007/s13365-023-01119-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-023-01119-1</ArticleId><ArticleId IdType="pmc">PMC9888322</ArticleId><ArticleId IdType="pubmed">36719594</ArticleId></ArticleIdList></Reference><Reference><Citation>Kokkoris S., Stamataki E., Emmanouil G., Psachoulia C., Ntaidou T., Maragouti A., Kanavou A., Malachias S., Christodouli F., Papachatzakis I., et al. Serum inflammatory and brain injury biomarkers in COVID-19 patients admitted to intensive care unit: A pilot study. eNeurologicalSci. 2022;29:100434. doi: 10.1016/j.ensci.2022.100434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ensci.2022.100434</ArticleId><ArticleId IdType="pmc">PMC9632260</ArticleId><ArticleId IdType="pubmed">36348961</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahin B.E., Celikbilek A., Kocak Y., Saltoglu G.T., Konar N.M., Hizmali L. Plasma biomarkers of brain injury in COVID-19 patients with neurological symptoms. J. Neurol. Sci. 2022;439:120324. doi: 10.1016/j.jns.2022.120324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120324</ArticleId><ArticleId IdType="pmc">PMC9212259</ArticleId><ArticleId IdType="pubmed">35752131</ArticleId></ArticleIdList></Reference><Reference><Citation>Passos F.R.S., Heimfarth L., Monteiro B.S., Corr&#xea;a C.B., Moura TRd Ara&#xfa;jo A.A.d.S., Martins-Filho P.R., Quintans-J&#xfa;nior L.J., Quintans J.S.S. Oxidative stress and inflammatory markers in patients with COVID-19: Potential role of RAGE, HMGB1, GFAP and COX-2 in disease severity. Int. Immunopharmacol. 2022;104:108502. doi: 10.1016/j.intimp.2021.108502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.108502</ArticleId><ArticleId IdType="pmc">PMC8730710</ArticleId><ArticleId IdType="pubmed">35063743</ArticleId></ArticleIdList></Reference><Reference><Citation>Frithiof R., Rostami E., Kumlien E., Virhammar J., F&#xe4;llmar D., Hultstr&#xf6;m M., Lipcsey M., Ashton N., Blennow K., Zetterberg H., et al. Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective study. Clin. Neurophysiol. Off. J. Int. Fed. Clin. Neurophysiol. 2021;132:1733&#x2013;1740. doi: 10.1016/j.clinph.2021.03.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2021.03.016</ArticleId><ArticleId IdType="pmc">PMC8012169</ArticleId><ArticleId IdType="pubmed">33875374</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokic D., Mikacic M., Kumric M., Ticinovic Kurir T., Rancic I., Martinovic D., Bukic J., Vrdoljak J., Lizatovic I.K., Stipic S.S., et al. Association between Brain Injury Markers and Testosterone in Critically-Ill COVID-19 Male Patients. Microorganisms. 2022;10:2095. doi: 10.3390/microorganisms10112095.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms10112095</ArticleId><ArticleId IdType="pmc">PMC9697553</ArticleId><ArticleId IdType="pubmed">36363686</ArticleId></ArticleIdList></Reference><Reference><Citation>Plantone D., Locci S., Bergantini L., Manco C., Cortese R., Meocci M., Cavallaro D., d&#x2019;Alessandro M., Bargagli E., De Stefano N. Brain neuronal and glial damage during acute COVID-19 infection in absence of clinical neurological manifestations. J. Neurol. Neurosurg. Psychiatry. 2022;93:1343&#x2013;1348. doi: 10.1136/jnnp-2022-329933.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2022-329933</ArticleId><ArticleId IdType="pubmed">36137741</ArticleId></ArticleIdList></Reference><Reference><Citation>Lennol M.P., Ashton N.J., Moreno-P&#xe9;rez O., Garc&#xed;a-Ayll&#xf3;n M.-S., Ramos-Rincon J.-M., Andr&#xe9;s M., Le&#xf3;n-Ram&#xed;rez J.M., Boix V., Gil J., Blennow K., et al. Transient Changes in the Plasma of Astrocytic and Neuronal Injury Biomarkers in COVID-19 Patients without Neurological Syndromes. Int. J. Mol. Sci. 2023;24:2715. doi: 10.3390/ijms24032715.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24032715</ArticleId><ArticleId IdType="pmc">PMC9917569</ArticleId><ArticleId IdType="pubmed">36769057</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonetto V., Pasetto L., Lisi I., Carbonara M., Zangari R., Ferrari E., Punzi V., Luotti S., Bottino N., Biagianti B., et al. Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations. Front. Immunol. 2022;13:1070379. doi: 10.3389/fimmu.2022.1070379.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1070379</ArticleId><ArticleId IdType="pmc">PMC9798841</ArticleId><ArticleId IdType="pubmed">36591311</ArticleId></ArticleIdList></Reference><Reference><Citation>Savarraj J., Park E.S., Colpo G.D., Hinds S.N., Morales D., Ahnstedt H., Paz A.S., Assing A., Liu F., Juneja S., et al. Brain injury, endothelial injury and inflammatory markers are elevated and express sex-specific alterations after COVID-19. J. Neuroinflamm. 2021;18:277. doi: 10.1186/s12974-021-02323-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-021-02323-8</ArticleId><ArticleId IdType="pmc">PMC8627162</ArticleId><ArticleId IdType="pubmed">34838058</ArticleId></ArticleIdList></Reference><Reference><Citation>de Boni L., Odainic A., Gancarczyk N., Kaluza L., Strassburg C.P., Kersting X.A.K., Johnson J.M., W&#xfc;llner U., Schmidt S.V., Nattermann J., et al. No serological evidence for neuronal damage or reactive gliosis in neuro-COVID-19 patients with long-term persistent headache. Neurol. Res. Pract. 2022;4:53. doi: 10.1186/s42466-022-00217-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42466-022-00217-5</ArticleId><ArticleId IdType="pmc">PMC9618412</ArticleId><ArticleId IdType="pubmed">36310154</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanberg N., Simr&#xe9;n J., Ed&#xe9;n A., Andersson L.-M., Nilsson S., Ashton N.J., Sundvall P.D., Nellg&#xe5;rd B., Blennow K., Zetterberg H., et al. Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up. EBioMedicine. 2021;70:103512. doi: 10.1016/j.ebiom.2021.103512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103512</ArticleId><ArticleId IdType="pmc">PMC8320425</ArticleId><ArticleId IdType="pubmed">34333238</ArticleId></ArticleIdList></Reference><Reference><Citation>Spanos M., Shachar S., Sweeney T., Lehmann H.I., Gokulnath P., Li G., Sigal G.B., Nagaraj R., Bathala P., Rana F., et al. Elevation of neural injury markers in patients with neurologic sequelae after hospitalization for SARS-CoV-2 infection. iScience. 2022;25:104833. doi: 10.1016/j.isci.2022.104833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.104833</ArticleId><ArticleId IdType="pmc">PMC9341164</ArticleId><ArticleId IdType="pubmed">35937088</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson B.A., Visvabharathy L., Ali S.T., Kang A.K., Patel T.R., Clark J.R., Lim P.H., Orban Z.S., Hwang S.S., Mattoon D., et al. Plasma Biomarkers of Neuropathogenesis in Hospitalized Patients with COVID-19 and Those with Postacute Sequelae of SARS-CoV-2 Infection. Neurol. (R) Neuroimmunol. Neuroinflamm. 2022;9:e1151. doi: 10.1212/NXI.0000000000001151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001151</ArticleId><ArticleId IdType="pmc">PMC8901169</ArticleId><ArticleId IdType="pubmed">35256481</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Sans H.M., Forman C.A., Nylander A.N., Ho H.-E., Lu S., Goldberg S.A., Hoh R., Tai V., Munter S.E., et al. Plasma Markers of Neurologic Injury and Inflammation in People with Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 Infection. Neurol. (R) Neuroimmunol. Neuroinflamm. 2022;9:e200003. doi: 10.1212/NXI.0000000000200003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000200003</ArticleId><ArticleId IdType="pmc">PMC9210548</ArticleId><ArticleId IdType="pubmed">35701186</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T., Jolley S.E., Karlson E.W., Levitan E.B., Levy B., McComsey G.A., McCorkell L., Nadkarni G.N., Parthasarathy S., Singh U., et al. Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. JAMA. 2023;329:1934&#x2013;1946. doi: 10.1001/jama.2023.8823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.8823</ArticleId><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang A.C., Kern F., Losada P.M., Agam M.R., Maat C.A., Schmartz G.P., Fehlmann T., Stein J.A., Schaum N., Lee D.P., et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature. 2021;595:565&#x2013;571. doi: 10.1038/s41586-021-03710-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03710-0</ArticleId><ArticleId IdType="pmc">PMC8400927</ArticleId><ArticleId IdType="pubmed">34153974</ArticleId></ArticleIdList></Reference><Reference><Citation>Bussani R., Zentilin L., Correa R., Colliva A., Silvestri F., Zacchigna S., Collesi C., Giacca M. Persistent SARS-CoV-2 infection in patients seemingly recovered from COVID-19. J. Pathol. 2023;259:254&#x2013;263. doi: 10.1002/path.6035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.6035</ArticleId><ArticleId IdType="pmc">PMC10107739</ArticleId><ArticleId IdType="pubmed">36651103</ArticleId></ArticleIdList></Reference><Reference><Citation>Virhammar J., Kumlien E., F&#xe4;llmar D., Frithiof R., Jackmann S., Sk&#xf6;ld M.K., Kadir M., Frick J., Lindeberg J., Olivero-Reinius H., et al. Acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluid. Neurology. 2020;95:445&#x2013;449. doi: 10.1212/WNL.0000000000010250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010250</ArticleId><ArticleId IdType="pmc">PMC7538220</ArticleId><ArticleId IdType="pubmed">32586897</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews M.G., Mukhtar T., Eze U.C., Simoneau C.R., Ross J., Parikshak N., Wang S., Zhou L., Koontz M., Velmeshev D., et al. Tropism of SARS-CoV-2 for human cortical astrocytes. Proc. Natl. Acad. Sci. USA. 2022;119:e2122236119. doi: 10.1073/pnas.2122236119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2122236119</ArticleId><ArticleId IdType="pmc">PMC9335272</ArticleId><ArticleId IdType="pubmed">35858406</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S., Fishell G. In SARS-CoV-2, astrocytes are in it for the long haul. Proc. Natl. Acad. Sci. USA. 2022;119:e2209130119. doi: 10.1073/pnas.2209130119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2209130119</ArticleId><ArticleId IdType="pmc">PMC9335203</ArticleId><ArticleId IdType="pubmed">35858460</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosu G.C., Mateescu V.O., Simionescu A., Istrate-Ofiteru A.-M., Curc&#x103; G.C., Pirici I., Mogoanta L., Mindrila I., Kumar-Singh S., Hostiuc S., et al. Subtle vascular and astrocytic changes in the brain of coronavirus disease 2019 (COVID-19) patients. Eur. J. Neurol. 2022;29:3676&#x2013;3692. doi: 10.1111/ene.15545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15545</ArticleId><ArticleId IdType="pmc">PMC9539405</ArticleId><ArticleId IdType="pubmed">36056566</ArticleId></ArticleIdList></Reference><Reference><Citation>Etter M.M., Martins T.A., Kulsvehagen L., P&#xf6;ssnecker E., Duchemin W., Hogan S., Sanabria-Diaz G., M&#xfc;ller J., Chiappini A., Rychen J., et al. Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: A prospective cross-sectional study. Nat. Commun. 2022;13:6777. doi: 10.1038/s41467-022-34068-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34068-0</ArticleId><ArticleId IdType="pmc">PMC9645766</ArticleId><ArticleId IdType="pubmed">36351919</ArticleId></ArticleIdList></Reference><Reference><Citation>Serafini G., Costanza A., Aguglia A., Amerio A., Trabucco A., Escelsior A., Sher L., Amore M. The Role of Inflammation in the Pathophysiology of Depression and Suicidal Behavior. Med. Clin. N. Am. 2023;107:1&#x2013;29. doi: 10.1016/j.mcna.2022.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcna.2022.09.001</ArticleId><ArticleId IdType="pubmed">36402492</ArticleId></ArticleIdList></Reference><Reference><Citation>Pompili M., Gentile G., Scassellati C., Bonvicini C., Innamorati M., Erbuto D., Montebovi F., Ducci G., Forte A., De Pisa E., et al. Genetic association analysis of serotonin and signal transduction pathways in suicide attempters from an Italian sample of psychiatric patients. Neurosci. Lett. 2017;656:94&#x2013;102. doi: 10.1016/j.neulet.2017.07.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.07.020</ArticleId><ArticleId IdType="pubmed">28716530</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel U.K., Mehta N., Patel A., Patel N., Ortiz J.F., Khurana M., Urhoghide E., Parulekar A., Bhriguvanshi A., Patel N., et al. Long-Term Neurological Sequelae Among Severe COVID-19 Patients: A Systematic Review and Meta-Analysis. Cureus. 2022;14:e29694. doi: 10.7759/cureus.29694.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.29694</ArticleId><ArticleId IdType="pmc">PMC9616013</ArticleId><ArticleId IdType="pubmed">36321004</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasnier M., Choucha W., Radiguer F., Faulet T., Chappell K., Bougarel A., Kondarjian C., Thorey P., Baldacci A., Ballerini M., et al. Comorbidity of long COVID and psychiatric disorders after a hospitalisation for COVID-19: A cross-sectional study. J. Neurol. Neurosurg. Psychiatry. 2022;93:1091&#x2013;1098. doi: 10.1136/jnnp-2021-328516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2021-328516</ArticleId><ArticleId IdType="pubmed">35953265</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodward S.F., Bari S., Vike N., Lalvani S., Stetsiv K., Kim B.W., Stefanopoulos L., Maglaveras N., Breiter H., Katsaggelos A.K. Anxiety, Post-COVID-19 Syndrome-Related Depression, and Suicidal Thoughts and Behaviors in COVID-19 Survivors: Cross-sectional Study. JMIR Form. Res. 2022;6:e36656. doi: 10.2196/36656.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/36656</ArticleId><ArticleId IdType="pmc">PMC9604174</ArticleId><ArticleId IdType="pubmed">35763757</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaumont H., Meppiel E., Roze E., Tressi&#xe8;res B., de Broucker T., Lannuzel A., contributors to the French NeuroCOVID registry Long-term outcomes after NeuroCOVID: A 6-month follow-up study on 60 patients. Rev. Neurol. 2022;178:137&#x2013;143. doi: 10.1016/j.neurol.2021.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2021.12.008</ArticleId><ArticleId IdType="pmc">PMC9753577</ArticleId><ArticleId IdType="pubmed">35000793</ArticleId></ArticleIdList></Reference><Reference><Citation>Damiano R.F., Caruso M.J.G., Cincoto A.V., de Almeida Rocca C.C., de P&#xe1;dua Serafim A., Bacchi P., Guedes B.F., Brunoni A.R., Pan P.M., Nitrini R., et al. Post-COVID-19 psychiatric and cognitive morbidity: Preliminary findings from a Brazilian cohort study. Gen. Hosp. Psychiatry. 2022;75:38&#x2013;45. doi: 10.1016/j.genhosppsych.2022.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2022.01.002</ArticleId><ArticleId IdType="pmc">PMC8734055</ArticleId><ArticleId IdType="pubmed">35134702</ArticleId></ArticleIdList></Reference><Reference><Citation>Paradowska-Nowakowska E., &#x141;oboda D., Go&#x142;ba K.S., Sarecka-Hujar B. Long COVID-19 Syndrome Severity According to Sex, Time from the Onset of the Disease, and Exercise Capacity-The Results of a Cross-Sectional Study. Life. 2023;13:508. doi: 10.3390/life13020508.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life13020508</ArticleId><ArticleId IdType="pmc">PMC9961608</ArticleId><ArticleId IdType="pubmed">36836865</ArticleId></ArticleIdList></Reference><Reference><Citation>Alghamdi H.Y., Alrashed A.M., Jawhari A.M., Abdel-Moneim A.S. Neuropsychiatric symptoms in post-COVID-19 long haulers. Acta Neuropsychiatr. 2022;34:318&#x2013;329. doi: 10.1017/neu.2022.13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/neu.2022.13</ArticleId><ArticleId IdType="pubmed">35543105</ArticleId></ArticleIdList></Reference><Reference><Citation>Magn&#xfa;sd&#xf3;ttir I., Lovik A., Unnarsd&#xf3;ttir A.B., McCartney D., Ask H., K&#xf5;iv K., Christoffersen L.A.N., Johnson S.U., Hauksd&#xf3;ttir A., Fawns-Ritchie C., et al. Acute COVID-19 severity and mental health morbidity trajectories in patient populations of six nations: An observational study. Lancet. Public Health. 2022;7:e406&#x2013;e416. doi: 10.1016/S2468-2667(22)00042-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(22)00042-1</ArticleId><ArticleId IdType="pmc">PMC8920517</ArticleId><ArticleId IdType="pubmed">35298894</ArticleId></ArticleIdList></Reference><Reference><Citation>Su W., Ju J., Gu M., Wang X., Liu S., Yu J., Mu D. SARS-CoV-2 envelope protein triggers depression-like behaviors and dysosmia via TLR2-mediated neuroinflammation in mice. J. Neuroinflamm. 2023;20:110. doi: 10.1186/s12974-023-02786-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-023-02786-x</ArticleId><ArticleId IdType="pmc">PMC10166055</ArticleId><ArticleId IdType="pubmed">37158916</ArticleId></ArticleIdList></Reference><Reference><Citation>Paidas M.J., Cosio D.S., Ali S., Kenyon N.S., Jayakumar A.R. Long-Term Sequelae of COVID-19 in Experimental Mice. Mol. Neurobiol. 2022;59:5970&#x2013;5986. doi: 10.1007/s12035-022-02932-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-022-02932-1</ArticleId><ArticleId IdType="pmc">PMC9281331</ArticleId><ArticleId IdType="pubmed">35831558</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasirpour N., Esmailzadehha N., Hajebi A., Savari E., Ghanbari B., Motevalian A. Preexisting depression and COVID-19: A cohort study on the risk of susceptibility and hospitalization. BMC Psychiatry. 2023;23:942. doi: 10.1186/s12888-023-05438-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12888-023-05438-9</ArticleId><ArticleId IdType="pmc">PMC10720084</ArticleId><ArticleId IdType="pubmed">38093243</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenblatt-Kimron L., Shinan-Altman S., Alperin M., Levkovich I. Depression and Medicine Use among Older Adults during the COVID-19 Pandemic: The Role of Psychosocial Resources and COVID-19 Perceived Susceptibility. Int. J. Env. Res. Public Health. 2023;20:3398. doi: 10.3390/ijerph20043398.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20043398</ArticleId><ArticleId IdType="pmc">PMC9961318</ArticleId><ArticleId IdType="pubmed">36834090</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado-Alonso C., Valles-Salgado M., Delgado-&#xc1;lvarez A., G&#xf3;mez-Ruiz N., Yus M., Polidura C., P&#xe9;rez-Izquierdo C., Marcos A., Gil M.J., Mat&#xed;as-Guiu J., et al. Examining Association of Personality Characteristics and Neuropsychiatric Symptoms in Post-COVID Syndrome. Brain Sci. 2022;12:265. doi: 10.3390/brainsci12020265.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci12020265</ArticleId><ArticleId IdType="pmc">PMC8870488</ArticleId><ArticleId IdType="pubmed">35204028</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazemi Arababadi M., Abdollahi S.H., Ramezani M., Zare-Bidaki M. A Review of Immunological and Neuropsychobehavioral Effects of Latent Toxoplasmosis on Humans. Parasite Immunol. 2024;46:e13060. doi: 10.1111/pim.13060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pim.13060</ArticleId><ArticleId IdType="pubmed">39072801</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung S.J., Lim S.S., Yoon J.H. Fluctuations in influenza-like illness epidemics and suicide mortality: A time-series regression of 13-year mortality data in South Korea. PLoS ONE. 2021;16:e0244596. doi: 10.1371/journal.pone.0244596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0244596</ArticleId><ArticleId IdType="pmc">PMC7880447</ArticleId><ArticleId IdType="pubmed">33577567</ArticleId></ArticleIdList></Reference><Reference><Citation>Yip P.S., Cheung Y.T., Chau P.H., Law Y.W. The impact of epidemic outbreak: The case of severe acute respiratorysyndrome (SARS) and suicide among older adults in Hong Kong. Crisis. 2010;31:86&#x2013;92. doi: 10.1027/0227-5910/a000015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1027/0227-5910/a000015</ArticleId><ArticleId IdType="pubmed">20418214</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn S.H., Kim J.L., Kim J.R., Lee S.H., Yim H.W., Jeong H., Chae J.H., Park H.Y., Lee J.J., Lee H. Association between chronic fatigue syndrome and suicidality among survivors of Middle East respiratory syndrome over a 2-year follow-up period. J. Psychiatr. Res. 2021;137:1&#x2013;6. doi: 10.1016/j.jpsychires.2021.02.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2021.02.029</ArticleId><ArticleId IdType="pmc">PMC7888998</ArticleId><ArticleId IdType="pubmed">33631632</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn S.H., Kim J.L., Lee S.H., Park H.Y., Lee J.J., Lee H. Associations of health-related quality of life with depression and stigma in MERS-CoV survivors during the recovery period. Medicine 2022. 2022;101:e29440. doi: 10.1097/MD.0000000000029440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000029440</ArticleId><ArticleId IdType="pmc">PMC9276386</ArticleId><ArticleId IdType="pubmed">35758380</ArticleId></ArticleIdList></Reference><Reference><Citation>Boden M., Cohen N., Froelich J.M., Hoggatt K.J., Abdel Magid H.S., Mushiana S.S. Mental disorder prevalence among populations impacted by coronavirus pandemics: A multilevel meta-analytic study of COVID-19, MERS &amp; SARS. Gen. Hosp. Psychiatry. 2021;70:124&#x2013;133. doi: 10.1016/j.genhosppsych.2021.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2021.03.006</ArticleId><ArticleId IdType="pmc">PMC8058549</ArticleId><ArticleId IdType="pubmed">33894561</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahil K., Cheaito M.A., El Hayek R., Nofal M., El Halabi S., Pereira-Sanchez V., El Hayek S. Suicide during COVID-19 and other major international respiratory outbreaks: A systematic review. Asian J. Psychiatr. 2021;56:102509. doi: 10.1016/j.ajp.2020.102509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajp.2020.102509</ArticleId><ArticleId IdType="pmc">PMC7764387</ArticleId><ArticleId IdType="pubmed">33418284</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers J.P., Chesney E., Oliver D., Begum N., Saini A., Wang S., McGuire P., Fusar-Poli P., Lewis G., David A.S. Suicide, self-harm and thoughts of suicide or self-harm in infectious disease epidemics: A systematic review and meta-analysis. Epidemiol. Psychiatr. Sci. 2021;30:e32. doi: 10.1017/S2045796021000214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S2045796021000214</ArticleId><ArticleId IdType="pmc">PMC7610720</ArticleId><ArticleId IdType="pubmed">33902775</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagonabarraga J., &#xc1;lamo C., Castellanos M., D&#xed;az S., Manzano S. Depression in Major Neurodegenerative Diseases and Strokes: A Critical Review of Similarities and Differences among Neurological Disorders. Brain Sci. 2023;13:318. doi: 10.3390/brainsci13020318.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci13020318</ArticleId><ArticleId IdType="pmc">PMC9954482</ArticleId><ArticleId IdType="pubmed">36831861</ArticleId></ArticleIdList></Reference><Reference><Citation>Erlangsen A., Stenager E., Conwell Y., Andersen P.K., Hawton K., Benros M.E., Nordentoft M., Stenager E. Association between Neurological Disorders and Death by Suicide in Denmark. JAMA. 2020;323:444&#x2013;454. doi: 10.1001/jama.2019.21834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.21834</ArticleId><ArticleId IdType="pmc">PMC7042859</ArticleId><ArticleId IdType="pubmed">32016308</ArticleId></ArticleIdList></Reference><Reference><Citation>Song H., Lei N., Zeng L., Li X., Li X., Liu Y., Liu J., Wu W., Mu J., Feng Q. Genetic predisposition to subjective well-being, depression, and suicide in relation to COVID-19 susceptibility and severity. J. Affect. Disord. 2023;335:233&#x2013;238. doi: 10.1016/j.jad.2023.05.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2023.05.019</ArticleId><ArticleId IdType="pmc">PMC10174343</ArticleId><ArticleId IdType="pubmed">37178830</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong A.C., Devason A.S., Umana I.C., Cox T.O., Dohnalov&#xe1; L., Litichevskiy L., Perla J., Lundgren P., Etwebi Z., Izzo L.T., et al. Serotonin reduction in post-acute sequelae of viral infection. Cell. 2023;186:4851&#x2013;4867. doi: 10.1016/j.cell.2023.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2023.09.013</ArticleId><ArticleId IdType="pmc">PMC11227373</ArticleId><ArticleId IdType="pubmed">37848036</ArticleId></ArticleIdList></Reference><Reference><Citation>Yohn C.N., Gergues M.M., Samuels B.A. The role of 5-HT receptors in depression. Mol. Brain. 2017;10:28. doi: 10.1186/s13041-017-0306-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-017-0306-y</ArticleId><ArticleId IdType="pmc">PMC5483313</ArticleId><ArticleId IdType="pubmed">28646910</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>